AI Article Synopsis

  • A study examined racial disparities in high-dose influenza vaccine (HDV) receipt among Black and White traditional Medicare beneficiaries during the 2015-2016 flu season, finding a significant national disparity of 12.8 percentage points.
  • The analysis looked at data from over 11.7 million beneficiaries, revealing that Black individuals were consistently less likely to receive HDV compared to their White counterparts across most states and hospital referral regions (HRRs).
  • The disparities varied widely, with median differences of 10.7 pps at the state level and 11.6 pps at the HRR level, highlighting a need for targeted local interventions to address these inequities.

Article Abstract

Background: Racial disparities in receipt of high-dose influenza vaccine (HDV) have been documented nationally, but whether small-area geographic variation in such disparities exists remains unknown. We assessed the distribution of disparities in HDV receipt between Black and White traditional Medicare beneficiaries vaccinated against influenza within states and hospital referral regions (HRRs).

Methods: We conducted a nationally representative retrospective cohort study of 11,768,724 community-dwelling traditional Medicare beneficiaries vaccinated against influenza during the 2015-2016 influenza season (94.3% White and 5.7% Black). Our comparison was marginalized versus privileged racial group measured as Black versus White race. Vaccination and type of vaccine were obtained from Medicare Carrier and Outpatient files. Differences in the proportions of individuals who received HDV between Black and White beneficiaries within states and HRRs were used to measure age- and sex-standardized disparities in HDV receipt. We restricted to states and HRRs with ≥ 100 beneficiaries per age-sex strata per racial group.

Results: We detected a national disparity in HDV receipt of 12.8 percentage points (pps). At the state level, the median standardized HDV receipt disparity was 10.7 pps (minimum, maximum: 2.9, 25.6; n = 30 states). The median standardized HDV receipt disparity among HRRs was 11.6 pps (minimum, maximum: 0.4, 24.7; n = 54 HRRs).

Conclusion: Black beneficiaries were less likely to receive HDV compared to White beneficiaries in almost every state and HRR in our analysis. The magnitudes of disparities varied substantially across states and HRRs. Local interventions and policies are needed to target geographic areas with the largest disparities to address these inequities.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184628PMC
http://dx.doi.org/10.1007/s40615-023-01628-zDOI Listing

Publication Analysis

Top Keywords

hdv receipt
20
states hrrs
12
geographic variation
8
racial disparities
8
disparities receipt
8
receipt high-dose
8
high-dose influenza
8
influenza vaccine
8
hdv
8
disparities hdv
8

Similar Publications

Geographic Variation in Racial Disparities in Receipt of High-Dose Influenza Vaccine Among US Older Adults.

J Racial Ethn Health Disparities

June 2024

Department of Health Services, Policy, and Practice, Brown University School of Public Health, 121 South Main Street, Box G-S121-3, Providence, RI, USA.

Article Synopsis
  • A study examined racial disparities in high-dose influenza vaccine (HDV) receipt among Black and White traditional Medicare beneficiaries during the 2015-2016 flu season, finding a significant national disparity of 12.8 percentage points.
  • The analysis looked at data from over 11.7 million beneficiaries, revealing that Black individuals were consistently less likely to receive HDV compared to their White counterparts across most states and hospital referral regions (HRRs).
  • The disparities varied widely, with median differences of 10.7 pps at the state level and 11.6 pps at the HRR level, highlighting a need for targeted local interventions to address these inequities.
View Article and Find Full Text PDF

Background: Seasonal influenza vaccine (SIV) uptake among US adults aged 65 years or older remains suboptimal and stagnant. Further, there is growing concern around racial and ethnic disparities in uptake. We aimed to assess racial and ethnic disparities in overall SIV and in high-dose vaccine (HDV) uptake among Medicare beneficiaries during the 2015-16 influenza season and sought to identify possible mediators for observed disparities.

View Article and Find Full Text PDF

Objectives: The burden of hepatitis B virus (HBV) and hepatitis D virus (HDV) infections is unknown in Georgia. This analysis describes the prevalence of hepatitis B and coinfection with HDV and the demographic characteristics and risk factors for persons with HBV infection in Georgia.

Study Design: This is a cross-sectional seroprevalence study.

View Article and Find Full Text PDF

Delta hepatitis within the Veterans Affairs medical system in the United States: Prevalence, risk factors, and outcomes.

J Hepatol

September 2015

Division of Gastroenterology, University of Pennsylvania, Philadelphia, PA, United States; Department of Medicine, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, United States. Electronic address:

Background & Aims: Low hepatitis delta prevalence estimates in the United States are likely biased due to low testing rates. The objectives of this study were to quantify the prevalence of testing and identify factors associated with hepatitis D positive status among chronic hepatitis B patients in the Veterans Health Administration.

Methods: We performed a nationwide retrospective study of all veterans who tested positive for HBsAg from October 1999 to December 2013.

View Article and Find Full Text PDF

Background: A survey was performed in 2008 to evaluate the profiles of patients with chronic hepatitis B cared for by Italian Infectious Diseases Centers (IDCs). This analysis describes: i) factors associated with access to the anti-HBV treatment in a cohort of HIV/HBV co-infected patients cared for in tertiary centers of a developed country with comprehensive coverage under the National Health System (NHS); ii) consistency of current anti-HBV regimens with specific European guidelines in force at the time of the study and factors associated with the receipt of sub-optimal regimens.

Methods: The study focuses on 374 (87.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!